These findings suggest that, in addition to promoting CTNND1 palmitoylation in melanoma cells, ZDHHC13 may also stabilize E-cadherin in melanoma cells by reducing LPC levels in the TME and suppressing MMP12 expression in M2-like TAMs. The gene discussed is ZDHHC13; the disease is melanoma.